PIII
P3 Health Partners Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$9.35
+2.41%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 1.5B | 1.5B | 1.3B | 1.0B |
| Cost of Revenue | 1.0B | 1.6B | — | — | — |
| Gross Profit | 475.6M | (144.3M) | 1.5B | 1.3B | 1.0B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 116.8M | 107.2M | 113.9M | 125.6M | 162.4M |
| General & Admin Expense | 116.0M | 106.3M | 112.6M | 122.4M | 157.3M |
| Selling & Marketing Expense | 813.0K | 918.0K | 1.3M | 3.2M | 5.1M |
| Other Expenses | 507.4M | 18.7M | 1.7B | 1.3B | 2.4B |
| Total Operating Expenses | 624.2M | 126.0M | 1.8B | 1.4B | 2.6B |
| Cost and Expenses | 1.7B | 1.7B | 1.8B | 1.4B | 2.6B |
| Operating Income (EBIT) | (148.6M) | (270.3M) | (312.6M) | (167.9M) | (1.6B) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 60.8M | 55.0M | 22.2M | 16.0M | 11.4M |
| Net Interest Income | (60.8M) | (55.0M) | (22.2M) | (16.0M) | (11.4M) |
| Other Non-Op Income/Expense | (78.6M) | (50.8M) | 6.6M | (15.8M) | 1.2M |
| Non-Operating Income (excl Interest) | 17.8M | (4.3M) | (28.8M) | (184.0K) | (12.6M) |
| EBT (Pre-Tax Income) | (227.2M) | (321.1M) | (306.0M) | (183.7M) | (1.6B) |
| Income Tax Expense | 7.8M | 2.0M | 4.4M | 2.7M | 1.9M |
| Bottom Line | |||||
| Net Income | (98.4M) | (147.9M) | (135.8M) | (57.8M) | (270.1M) |
| Earnings from Cont. Ops | (235.1M) | (323.1M) | (310.4M) | (186.4M) | (1.6B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (108.0M) | (147.9M) | (158.9M) | (57.8M) | (270.1M) |
| Per Share | |||||
| Basic EPS | ($32.95) | ($45.26) | ($46.79) | ($30.44) | ($324.84) |
| Diluted EPS | ($32.95) | ($45.26) | ($54.06) | ($30.44) | ($324.84) |
| Revenue Per Share | $447.01 | $446.34 | $516.77 | $667.29 | $1,262.02 |
| Shares | |||||
| Basic Shares Outstanding | 3.4M | 3.3M | 2.9M | 1.9M | 831580 |
| Diluted Shares Outstanding | 3.4M | 3.3M | 2.9M | 1.9M | 831580 |
| Profitability Metrics | |||||
| EBITDA | (82.3M) | (181.9M) | (197.8M) | (81.1M) | (1.5B) |
| D&A | 84.1M | 84.2M | 86.1M | 86.7M | 87.3M |
| EBIT | (166.5M) | (266.0M) | (283.8M) | (167.7M) | (1.5B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026